BioHealth News Archive
CMS names 25 innovators advancing in AI Health Outcomes Challenge | Healthcare IT News
The Centers for Medicare and Medicare Services this week announced the 25 participants selected to move on to the next round of its Artificial…
Read MoreEx-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics – Reuters
NEW YORK (Reuters) - As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few…
Read MoreGottlieb’s VC Focus | GenomeWeb
The former commissioner of the US Food and Drug Administration, Scott Gottlieb, tells Reuters that in his new role as a venture capitalist, he…
Read MoreEmerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome · BioBuzz
GAITHERSBURG, Md., Oct. 31, 2019 (GLOBE NEWSWIRE) — NexImmune, a clinical stage immunotherapy company developing novel T cell therapies, received Investigational New Drug (IND)…
Read MoreNeoProgen, led by former Harpoon Medical CEO, raises $1.5M from Maryland investors – BioHealth Capital Region
The biotech company is developing a cell therapy that could help patients who have suffered a heart attack. It’s the latest company led by…
Read MoreAssociation of University Research Parks (AURP) Opens in Maryland.
To cap off the TEDCO Entrepreneur Expo, there was a special ribbon cutting ceremony to welcome the Association of University Research Parks (AURP) to…
Read MoreBio Networking: Fermenting Innovation · BioBuzz
AstraZeneca and BioHealth Innovations, Inc is hosting the semi-annual Bio Networking event on November 6th from 3pm-5pm at the AstraZeneca Campus in Gaithersburg, MD.…
Read MoreMichael Lenardo, M.D., Chief, Molecular Development of the Immune System Section NIAID/DIR, guests on BioTalk
Michael Lenardo, M.D., Chief, Molecular Development of the Immune System Section NIAID/DIR, joins Rich Bendis on BioTalk to discuss his work at NIH, his…
Read MoreSecond Annual BioHealth Capital Investment Conference Expands With International Participation from New investors and Companies · BioBuzz
The second annual Biohealth Capital Region Investment Conference attracted 108 companies and 47 participating investors—both conference records—and has already resulted in an investment deal…
Read MoreMeet with Johnson & Johnson Innovation – Ogilvy Washington
On Thursday, November 7, join JLABS @ Washington, DC as representatives from Johnson & Johnson Innovation provide an overview of goals and mission, highlighting…
Read MoreBioTalk from the BioHealth Capital Region Investor Forum – Super Angel Investor, Dr. Faz Bashi, M.D.
Super Angel Investor, Faz Bashi, MD, guests on BioTalk from the BioHealth Capital Region Investor Conference to talk about his background in Immunology/Virology, Venture…
Read MoreBioTalk from the BioHealth Capital Region Investor Forum – Cartesian Therapeutics’ President & CEO Murat Kalayoglu, MD, Ph.D.
Cartesian Therapeutics’ President & CEO Murat Kalayoglu, MD, Ph.D., guests on BioTalk from the BioHealth Capital Region Investor Conference to talk about developing novel…
Read MoreMaryland University Trusts Drones With Organ Delivery | Voice of America – English
Drones are being taught to deliver food and medical supplies to customers. Now, doctors and scientists at the University of Maryland at College Park…
Read MoreTop 10 Asia Biopharma Clusters 2019
A year after transactions involving “research and development in biotechnology” and 26 other “critical technology” industries were made subject to review by the Committee…
Read MoreU.S. Funding for University Research Continues to Slide | ITIF
The United States continues to fall further behind world leaders in funding for university research. To reverse course, it should increase support by $45…
Read More